Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
AACE Endocrinology and Diabetes|July 18, 2025
Successful Treatment of Hypothalamic Obesity with TirzepatideSharmela Brijmohan, Jamie A MullallyCase Reports in Endocrinology|April 24, 2023
Thyrotoxicosis after COVID-19 Infection with a Delay in Graves' Disease Antibody PositivityDennis C Boyle, Jamie A MullallyThe American Journal of Case Reports|September 30, 2025
Severe Liver Dysfunction Within 48 Hours of Thionamide Therapy in Thyrotoxicosis: A Case ReportChristopher Annabi, Laila Noor, Jamie A MullallyCardiology in Review|January 23, 2023
Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?Joel Novograd, Jamie A Mullally, William H FrishmanCardiology in Review|December 26, 2024
The First Triple Agonist for Antiobesity: RetatrutideLauren Tetelbaun, Jamie A Mullally, William H FrishmanCardiology in Review|March 8, 2023
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of ObesityAntonella M D'Ascanio, Jamie A Mullally, William H FrishmanAACE Clinical Case Reports|October 7, 2024
Treatment of Bisphosphonate-Associated Atypical Femur Fracture With a Combination of Teriparatide and a Novel Surgical TechniqueAditi H Chincholi, Anna R Cooper, Jamie A MullallyJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 28, 2023
New-onset persistent hyperglycemia with initiation of brentuximab treatmentJoseph Quintas, Kelley B Mowatt, Jamie A Mullally, et al.Scientific Reports|February 14, 2019
Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 DiabetesJamie A Mullally, Gerardo J Febres, Marc Bessler, et al.Cardiology in Review|December 17, 2024
Oral GLP-1 Receptor Agonists for Weight LossDana Krinsky, Avraham Marcucci, Jamie A Mullally, et al.Pageof 2